Vaccination with LAG-3Ig (IMP321) and Peptides Induces Specific CD4 and CD8 T-Cell Responses in Metastatic Melanoma Patients—Report of a Phase I/IIa Clinical Trial - Concepedia

Concepedia

Publication | Open Access

Vaccination with LAG-3Ig (IMP321) and Peptides Induces Specific CD4 and CD8 T-Cell Responses in Metastatic Melanoma Patients—Report of a Phase I/IIa Clinical Trial

DOI Full Paper Access

93

Citations

32

References

2015

Year

Amandine Legat, Hélène Maby–El Hajjami, Petra Baumgaertner, Laurène Cagnon, Samia Abed Maillard, Christine Geldhof, Emanuela M. Iancu, Luc Lebon, Philippe Guillaume, Danijel Dojcinovic,

Clinical Cancer Research

Abstract

We conclude that vaccination with IMP321 is a promising and safe strategy for inducing sustained immune responses, encouraging further development for cancer vaccines as components of combination therapies.

References

	Year	Citations

Page 1